Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


19.04.2021

1 Arch Virol
3 BMJ
8 Cell
1 Drug Saf
6 Epidemiol Infect
5 J Gen Virol
2 J Immunol
7 J Infect Dis
5 J Virol Methods
1 JAMA
11 Lancet
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
2 PLoS Biol
3 PLoS Comput Biol
46 PLoS One
10 Proc Natl Acad Sci U S A
13 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. SYLVERKEN AA, El-Duah P, Owusu M, Schneider J, et al
    Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
    Arch Virol. 2021;166:1385-1393.
    PubMed         Abstract available


    BMJ

  2. ROSS JS
    Covid-19, open science, and the CVD-COVID-UK initiative.
    BMJ. 2021;373:n898.
    PubMed        

  3. WOOD A, Denholm R, Hollings S, Cooper J, et al
    Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
    BMJ. 2021;373:n826.
    PubMed         Abstract available

  4. SIMPSON PL, Levy M, Butler T
    Incarcerated people should be prioritised for covid-19 vaccination.
    BMJ. 2021;373:n859.
    PubMed        


    Cell

  5. ANDERSON EM, Goodwin EC, Verma A, Arevalo CP, et al
    Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
    Cell. 2021;184:1858-1864.
    PubMed         Abstract available

  6. SUN L, Li P, Ju X, Rao J, et al
    In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
    Cell. 2021;184:1865-1883.
    PubMed         Abstract available

  7. REN X, Wen W, Fan X, Hou W, et al
    COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
    Cell. 2021;184:1895-1913.
    PubMed         Abstract available

  8. ANDREANO E, Nicastri E, Paciello I, Pileri P, et al
    Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
    Cell. 2021;184:1821-1835.
    PubMed         Abstract available

  9. WINKLER ES, Gilchuk P, Yu J, Bailey AL, et al
    Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
    Cell. 2021;184:1804-1820.
    PubMed         Abstract available

  10. LIU C, Martins AJ, Lau WW, Rachmaninoff N, et al
    Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
    Cell. 2021;184:1836-1857.
    PubMed         Abstract available

  11. YU B, Qi Y, Li R, Shi Q, et al
    B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
    Cell. 2021;184:1790-1803.
    PubMed         Abstract available

  12. SCHULTZE JL, Aschenbrenner AC
    COVID-19 and the human innate immune system.
    Cell. 2021;184:1671-1692.
    PubMed         Abstract available


    Drug Saf

  13. GRANDVUILLEMIN A, Drici MD, Jonville-Bera AP, Micallef J, et al
    French Pharmacovigilance Public System and COVID-19 Pandemic.
    Drug Saf. 2021;44:405-408.
    PubMed         Abstract available


    Epidemiol Infect

  14. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    PubMed         Abstract available

  15. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    PubMed         Abstract available

  16. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    PubMed         Abstract available

  17. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    PubMed         Abstract available

  18. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    PubMed         Abstract available

  19. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    PubMed         Abstract available


    J Gen Virol

  20. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  21. AUERSWALD H, Yann S, Dul S, In S, et al
    Assessment of inactivation procedures for SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  22. ROE MK, Junod NA, Young AR, Beachboard DC, et al
    Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  23. GUPTA A, Sabarinathan R, Bala P, Donipadi V, et al
    A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

  24. MONCHATRE-LEROY E, Lesellier S, Wasniewski M, Picard-Meyer E, et al
    Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed         Abstract available


    J Immunol

  25. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
    Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    J Immunol. 2021;206:1691-1696.
    PubMed         Abstract available

  26. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
    Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
    J Immunol. 2020;205:3050-3057.
    PubMed         Abstract available


    J Infect Dis

  27. PETITO E, Falcinelli E, Paliani U, Cesari E, et al
    Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:933-944.
    PubMed         Abstract available

  28. IZURIETA HS, Graham DJ, Jiao Y, Hu M, et al
    Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
    J Infect Dis. 2021;223:945-956.
    PubMed         Abstract available

  29. STRICH JR, Ramos-Benitez MJ, Randazzo D, Stein SR, et al
    Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
    J Infect Dis. 2021;223:981-984.
    PubMed         Abstract available

  30. HUGHES EC, Amat JAR, Haney J, Parr YA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
    J Infect Dis. 2021;223:971-980.
    PubMed         Abstract available

  31. KLINGLER J, Weiss S, Itri V, Liu X, et al
    Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;223:957-970.
    PubMed         Abstract available

  32. ABBOUD H
    Encephalitis in the Setting of COVID-19 Infection.
    J Infect Dis. 2021;223:1303.
    PubMed        

  33. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed         Abstract available


    J Virol Methods

  34. VISSEAUX B, Collin G, Houhou-Fidouh N, Le Hingrat Q, et al
    Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
    J Virol Methods. 2021;291:114086.
    PubMed         Abstract available

  35. BLAND J, Kavanaugh A, Hong LK, Kadkol SS, et al
    Development and validation of viral load assays to quantitate SARS-CoV-2.
    J Virol Methods. 2021;291:114100.
    PubMed         Abstract available

  36. KOHMER N, Rabenau HF, Hoehl S, Kortenbusch M, et al
    Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs).
    J Virol Methods. 2021;291:114102.
    PubMed         Abstract available

  37. DAWSON ED, Kuck LR, Blair RH, Taylor AW, et al
    Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses.
    J Virol Methods. 2021;291:114111.
    PubMed         Abstract available

  38. PABBARAJU K, Wong AA, Ma R, Zelyas N, et al
    Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2.
    J Virol Methods. 2021 Apr 8:114151. doi: 10.1016/j.jviromet.2021.114151.
    PubMed        


    JAMA

  39. MASCOLA JR, Graham BS, Fauci AS
    SARS-CoV-2 Viral Variants-Tackling a Moving Target.
    JAMA. 2021 Feb 11. pii: 2776542. doi: 10.1001/jama.2021.2088.
    PubMed        


    Lancet

  40. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    PubMed        

  41. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    PubMed        

  42. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    PubMed        

  43. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    PubMed        

  44. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    PubMed        

  45. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    PubMed        

  46. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    PubMed         Abstract available

  47. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    PubMed        

  48. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    PubMed        

  49. THE LANCET
    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    PubMed        

  50. ZAROCOSTAS J
    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    PubMed        


    MMWR Morb Mortal Wkly Rep


  51. COVID-19 Stats: College and University* COVID-19 Student Testing Protocols,(dagger) by Mode of Instruction( section sign) (N = 1,849) - United States, Spring 2021( paragraph sign).
    MMWR Morb Mortal Wkly Rep. 2021;70:535.
    PubMed        

  52. MATTHIAS J, Charboneau T, Schaffer C, Rusten J, et al
    Notes from the Field: COVID-19 Case Investigation and Contact Tracing Program - Spirit Lake Tribe, North Dakota, September-November 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:533-534.
    PubMed        


    N Engl J Med

  53. RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
    Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
    N Engl J Med. 2021;384:e60.
    PubMed        

  54. ELIAS C, Nkengasong JN, Qadri F
    Emerging Infectious Diseases - Learning from the Past and Looking to the Future.
    N Engl J Med. 2021;384:1181-1184.
    PubMed        


    PLoS Biol

  55. RAVINDRA NG, Alfajaro MM, Gasque V, Huston NC, et al
    Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    PLoS Biol. 2021;19:e3001143.
    PubMed         Abstract available

  56. POHL MO, Busnadiego I, Kufner V, Glas I, et al
    SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    PLoS Biol. 2021;19:e3001006.
    PubMed         Abstract available


    PLoS Comput Biol

  57. HOLCOMB D, Alexaki A, Hernandez N, Hunt R, et al
    Gene variants of coagulation related proteins that interact with SARS-CoV-2.
    PLoS Comput Biol. 2021;17:e1008805.
    PubMed         Abstract available

  58. GONCALVES A, Maisonnasse P, Donati F, Albert M, et al
    SARS-CoV-2 viral dynamics in non-human primates.
    PLoS Comput Biol. 2021;17:e1008785.
    PubMed         Abstract available

  59. SIKORA M, von Bulow S, Blanc FEC, Gecht M, et al
    Computational epitope map of SARS-CoV-2 spike protein.
    PLoS Comput Biol. 2021;17:e1008790.
    PubMed         Abstract available


    PLoS One

  60. LYNG GD, Sheils NE, Kennedy CJ, Griffin DO, et al
    Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.
    PLoS One. 2021;16:e0248783.
    PubMed         Abstract available

  61. NOPSOPON T, Pongpirul K, Chotirosniramit K, Jakaew W, et al
    Seroprevalence of hospital staff in a province with zero COVID-19 cases.
    PLoS One. 2021;16:e0238088.
    PubMed         Abstract available

  62. SCALSKY RJ, Chen YJ, Desai K, O'Connell JR, et al
    Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank.
    PLoS One. 2021;16:e0248602.
    PubMed         Abstract available

  63. NAZIF-MUNOZ JI, Pena S, Oulhote Y
    The global viralization of policies to contain the spreading of the COVID-19 pandemic: Analyses of school closures and first reported cases.
    PLoS One. 2021;16:e0248828.
    PubMed         Abstract available

  64. HAWARI FI, Obeidat NA, Dodin YI, Albtoosh AS, et al
    The inevitability of Covid-19 related distress among healthcare workers: Findings from a low caseload country under lockdown.
    PLoS One. 2021;16:e0248741.
    PubMed         Abstract available

  65. VO DH, Doan B
    Effects from containment and closure policies to market quality: Do they really matter in Vietnam during Covid-19?
    PLoS One. 2021;16:e0248703.
    PubMed         Abstract available

  66. YU L, Halalau A, Dalal B, Abbas AE, et al
    Machine learning methods to predict mechanical ventilation and mortality in patients with COVID-19.
    PLoS One. 2021;16:e0249285.
    PubMed         Abstract available

  67. BHOWMIK T, Tirtha SD, Iraganaboina NC, Eluru N, et al
    A comprehensive analysis of COVID-19 transmission and mortality rates at the county level in the United States considering socio-demographics, health indicators, mobility trends and health care infrastructure attributes.
    PLoS One. 2021;16:e0249133.
    PubMed         Abstract available

  68. WANG Y, Zhao H
    Digital data-based strategies: A novel form of better understanding COVID-19 pandemic and international scientific collaboration.
    PLoS One. 2021;16:e0249280.
    PubMed         Abstract available

  69. SCOTT SM, Gross LJ
    COVID-19 and crime: Analysis of crime dynamics amidst social distancing protocols.
    PLoS One. 2021;16:e0249414.
    PubMed         Abstract available

  70. HAN CH, Kim M, Kwak JT
    Semi-supervised learning for an improved diagnosis of COVID-19 in CT images.
    PLoS One. 2021;16:e0249450.
    PubMed         Abstract available

  71. CHIMAMISE C, Munjanja SP, Machinga M, Shiripinda I, et al
    Impact of Covid-19 pandemic on obstetric fistula repair program in Zimbabwe.
    PLoS One. 2021;16:e0249398.
    PubMed         Abstract available

  72. FERRY AV, Keanie C, Denvir MA, Mills NL, et al
    Chest pain presentations to hospital during the COVID-19 lockdown: Lessons for public health media campaigns.
    PLoS One. 2021;16:e0249389.
    PubMed         Abstract available

  73. CLEMENT J, Jacobi M, Greenwood BN
    Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims.
    PLoS One. 2021;16:e0249453.
    PubMed         Abstract available

  74. JENKINS M, Hoek J, Jenkin G, Gendall P, et al
    Silver linings of the COVID-19 lockdown in New Zealand.
    PLoS One. 2021;16:e0249678.
    PubMed         Abstract available

  75. KASZTELEWICZ B, Janiszewska K, Burzynska J, Szydlowska E, et al
    Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    PLoS One. 2021;16:e0249550.
    PubMed         Abstract available

  76. GROS C, Valenti R, Schneider L, Gutsche B, et al
    Predicting the cumulative medical load of COVID-19 outbreaks after the peak in daily fatalities.
    PLoS One. 2021;16:e0247272.
    PubMed         Abstract available

  77. MARASHI MY, Nicholson E, Ogrodnik M, Fenesi B, et al
    A mental health paradox: Mental health was both a motivator and barrier to physical activity during the COVID-19 pandemic.
    PLoS One. 2021;16:e0239244.
    PubMed         Abstract available

  78. SEBASTIAO CS, Neto Z, Martinez P, Jandondo D, et al
    Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola.
    PLoS One. 2021;16:e0249249.
    PubMed         Abstract available

  79. POZDERAC C, Skinner B
    Superspreading of SARS-CoV-2 in the USA.
    PLoS One. 2021;16:e0248808.
    PubMed         Abstract available

  80. DIAS HG, Resck MEB, Caldas GC, Resck AF, et al
    Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil.
    PLoS One. 2021;16:e0248578.
    PubMed         Abstract available

  81. GILI T, Benelli G, Buscarini E, Canetta C, et al
    SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy.
    PLoS One. 2021;16:e0248498.
    PubMed         Abstract available

  82. AL DHAHERI AS, Bataineh MF, Mohamad MN, Ajab A, et al
    Impact of COVID-19 on mental health and quality of life: Is there any effect? A cross-sectional study of the MENA region.
    PLoS One. 2021;16:e0249107.
    PubMed         Abstract available

  83. AZUMA K, Nojiri T, Kawashima M, Hanai A, et al
    Possible favorable lifestyle changes owing to the coronavirus disease 2019 (COVID-19) pandemic among middle-aged Japanese women: An ancillary survey of the TRF-Japan study using the original "Taberhythm" smartphone app.
    PLoS One. 2021;16:e0248935.
    PubMed         Abstract available

  84. JOHNSON KE, Stoddard M, Nolan RP, White DE, et al
    In the long shadow of our best intentions: Model-based assessment of the consequences of school reopening during the COVID-19 pandemic.
    PLoS One. 2021;16:e0248509.
    PubMed         Abstract available

  85. WAGATSUMA K, Koolhof IS, Shobugawa Y, Saito R, et al
    Shifts in the epidemic season of human respiratory syncytial virus associated with inbound overseas travelers and meteorological conditions in Japan, 2014-2017: An ecological study.
    PLoS One. 2021;16:e0248932.
    PubMed         Abstract available

  86. OLIVEIRA E, Parikh A, Lopez-Ruiz A, Carrilo M, et al
    ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida.
    PLoS One. 2021;16:e0249038.
    PubMed         Abstract available

  87. DANTAS LF, Peres IT, Bastos LSL, Marchesi JF, et al
    App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning.
    PLoS One. 2021;16:e0248920.
    PubMed         Abstract available

  88. KOWALIK Z, Lewandowski P
    The gender gap in aversion to COVID-19 exposure: Evidence from professional tennis.
    PLoS One. 2021;16:e0249045.
    PubMed         Abstract available

  89. ADAMOU M, Jones SL, Fullen T, Galab N, et al
    Remote assessment in adults with Autism or ADHD: A service user satisfaction survey.
    PLoS One. 2021;16:e0249237.
    PubMed         Abstract available

  90. LEIGHT J, Hensly C, Chissano M, Ali L, et al
    Short-term effects of the COVID-19 state of emergency on contraceptive access and utilization in Mozambique.
    PLoS One. 2021;16:e0249195.
    PubMed         Abstract available

  91. CHU J
    A statistical analysis of the novel coronavirus (COVID-19) in Italy and Spain.
    PLoS One. 2021;16:e0249037.
    PubMed         Abstract available

  92. BOLLMANN A, Hohenstein S, Pellissier V, Stengler K, et al
    Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network.
    PLoS One. 2021;16:e0249251.
    PubMed         Abstract available

  93. WRIGHT L, Steptoe A, Fancourt D
    Are adversities and worries during the COVID-19 pandemic related to sleep quality? Longitudinal analyses of 46,000 UK adults.
    PLoS One. 2021;16:e0248919.
    PubMed         Abstract available

  94. HO IMK, Cheong KY, Weldon A
    Predicting student satisfaction of emergency remote learning in higher education during COVID-19 using machine learning techniques.
    PLoS One. 2021;16:e0249423.
    PubMed         Abstract available

  95. BYAMBASUREN O, Dobler CC, Bell K, Rojas DP, et al
    Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review.
    PLoS One. 2021;16:e0248946.
    PubMed         Abstract available

  96. WONG LP, Alias H, Md Fuzi AA, Omar IS, et al
    Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey.
    PLoS One. 2021;16:e0248916.
    PubMed         Abstract available

  97. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    PubMed         Abstract available

  98. SOOD N, Shetgiri R, Rodriguez A, Jimenez D, et al
    Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting.
    PLoS One. 2021;16:e0249710.
    PubMed         Abstract available

  99. HE S, Liu W, Jiang M, Huang P, et al
    Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study.
    PLoS One. 2021;16:e0249668.
    PubMed         Abstract available

  100. BASHETI IA, Mhaidat QN, Mhaidat HN
    Prevalence of anxiety and depression during COVID-19 pandemic among healthcare students in Jordan and its effect on their learning process: A national survey.
    PLoS One. 2021;16:e0249716.
    PubMed         Abstract available

  101. TKACIK PT, Dahlberg JL, Johnson JE, Hoth JJ, et al
    Sizing of airborne particles in an operating room.
    PLoS One. 2021;16:e0249586.
    PubMed         Abstract available

  102. SHARMA K, Aggarwala P, Gandhi D, Mathias A, et al
    Comparative analysis of various clinical specimens in detection of SARS-CoV-2 using rRT-PCR in new and follow up cases of COVID-19 infection: Quest for the best choice.
    PLoS One. 2021;16:e0249408.
    PubMed         Abstract available

  103. SELIGMAN H, Zaman S, Pitcher DS, Shun-Shin MJ, et al
    Reusable snorkel masks adapted as particulate respirators.
    PLoS One. 2021;16:e0249201.
    PubMed         Abstract available

  104. GARCIA-GORDILLO JA, Camiro-Zuniga A, Aguilar-Soto M, Cuenca D, et al
    COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19.
    PLoS One. 2021;16:e0248357.
    PubMed         Abstract available

  105. KREH A, Brancaleoni R, Magalini SC, Chieffo DPR, et al
    Ethical and psychosocial considerations for hospital personnel in the Covid-19 crisis: Moral injury and resilience.
    PLoS One. 2021;16:e0249609.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  106. BJERRE-NIELSEN A, Kassarnig V, Lassen DD, Lehmann S, et al
    Task-specific information outperforms surveillance-style big data in predictive analytics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  107. LI R
    Mobility restrictions are more than transient reduction of travel activities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        

  108. BERRY CR, Fowler A, Glazer T, Handel-Meyer S, et al
    Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  109. HE X, Quan S, Xu M, Rodriguez S, et al
    Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  110. RIZZI S, Vaupel JW
    Short-term forecasts of expected deaths.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  111. KRAUS S, Koch N
    Provisional COVID-19 infrastructure induces large, rapid increases in cycling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  112. YAN Y, Malik AA, Bayham J, Fenichel EP, et al
    Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  113. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  114. DAMIALIS A, Gilles S, Sofiev M, Sofieva V, et al
    Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  115. GIURGE LM, Whillans AV, Yemiscigil A
    A multicountry perspective on gender differences in time use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  116. KAUFMAN J, Attwell K, Tuckerman J, O'Sullivan J, et al
    Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30469.
    PubMed         Abstract available

  117. LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
    COVID-19 vaccine intentions in the United States, a social-ecological framework.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
    PubMed         Abstract available

  118. HAMILTON RA, Krockow EM, Vekria P
    Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
    PubMed         Abstract available

  119. SHEN M, Zu J, Fairley CK, Pagan JA, et al
    Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
    PubMed         Abstract available

  120. ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
    mRNA vaccines manufacturing: Challenges and bottlenecks.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
    PubMed         Abstract available

  121. PLOTKIN SA, Caplan A
    Extraordinary diseases require extraordinary solutions.
    Vaccine. 2020;38:3987-3988.
    PubMed        

  122. REPERANT LA, Osterhaus ADME
    COVID-19 vaccination and critical care capacity: Perilous months ahead.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.
    PubMed        

  123. ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
    The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
    PubMed         Abstract available

  124. POLUEKTOV Y, George M, Daftarian P, Delcommenne MC, et al
    Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
    Vaccine. 2021;39:2110-2116.
    PubMed         Abstract available

  125. SZIGETI R, Kellermayer R
    Natural unblinding of BCG vaccination trials.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
    PubMed         Abstract available

  126. SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
    Importance of COVID-19 vaccine efficacy in older age groups.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
    PubMed         Abstract available

  127. DU Y, Xu Y, Feng J, Hu L, et al
    Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
    PubMed         Abstract available

  128. ROBINSON E, Jones A, Lesser I, Daly M, et al
    International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
    Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
    PubMed         Abstract available


    Virology

  129. ZHIRNOV OP, Chlanda P
    The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.
    Virology. 2021;559:86-88.
    PubMed         Abstract available

  130. SEEKINGS AH, Warren CJ, Thomas SS, Mahmood S, et al
    Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry.
    Virology. 2021;559:74-85.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: